Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).

Saved in:

Bibliographic Details
Title:	Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).
Authors:	Edelmann F (AUTHOR), Schmidt AG (AUTHOR), Gelbrich G (AUTHOR), Binder L (AUTHOR), Herrmann-Lingen C (AUTHOR), Halle M (AUTHOR), Hasenfuss G (AUTHOR), Wachter R (AUTHOR), Pieske B (AUTHOR), Edelmann, Frank¹ (AUTHOR), Schmidt, Albrecht G (AUTHOR), Gelbrich, Götz (AUTHOR), Binder, Lutz (AUTHOR), Herrmann-Lingen, Christoph (AUTHOR), Halle, Martin (AUTHOR), Hasenfuss, Gerd (AUTHOR), Wachter, Rolf (AUTHOR), Pieske, Burkert (AUTHOR)
Source:	European Journal of Heart Failure. Aug2010, Vol. 12 Issue 8, p874-882. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	13889842
DOI:	10.1093/eurjhf/hfq087